• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原位和浸润性导管癌的遗传克隆图谱表明乳腺癌中的“癌化现象”。

Genetic clonal mapping of in situ and invasive ductal carcinoma indicates the field cancerization phenomenon in the breast.

机构信息

Department of Biomedical and Neuromuscular Sciences, "M. Malpighi" Anatomic Pathology Section, University of Bologna, Italy.

出版信息

Hum Pathol. 2013 Jul;44(7):1310-9. doi: 10.1016/j.humpath.2012.09.022. Epub 2013 Jan 18.

DOI:10.1016/j.humpath.2012.09.022
PMID:23337025
Abstract

Nearly 80% of well-differentiated in situ duct carcinomas (g1 DCIS) have been shown to be multicentric (multilobar) lesions, while most in situ poorly differentiated duct carcinomas (g3 DCIS) were unifocal (unilobar) lesions. Here we present a clonality study of 15 cases of DCIS, all showing multiple foci. Twelve of these cases were associated with an invasive duct carcinoma. Fifteen cases of female breast cancer patients all showing multiple DCIS foci (5 g1 DCIS, 5 g2 DCIS, 5 g3 DCIS) were randomly selected and histologically studied using large histological sections. Care was taken to laser-microdissect DCIS foci that were most distantly located from one another in the same large section, and pertinent cells were genetically studied. Invasive duct carcinoma and ipsilateral lymph node metastases and/or contralateral lesions, whenever present, were additionally microdissected. DNA of neoplastic cells was purified, and the mtDNA D-loop region was sequenced. Genetic distance of different foci from the same case was visualized by phylogenetic analyses using the neighbor-joining method. Patients ranged in age from 36 to 87 years (mean 65.1). All 9 cases of widely spread DCIS were not clonal. Four of 6 cases that showed multiple adjacent foci were clonally related on mtDNA analysis. In the present series, 11/15 DCIS appeared as multiple synchronous primary breast tumors, genetically not related to one another. The present data enhance the view that breast can also show the field cancerization phenomenon, paralleling what has already been proposed in other organs.

摘要

已有研究表明,近 80%分化良好的原位导管癌(g1 DCIS)为多灶性(多叶性)病变,而大多数分化不良的原位导管癌(g3 DCIS)为单灶性(单叶性)病变。在此,我们报告了 15 例 DCIS 的克隆性研究,所有病例均显示多个病灶。其中 12 例与浸润性导管癌相关。随机选择了 15 例女性乳腺癌患者的 15 例均显示多个 DCIS 病灶(5 例 g1 DCIS、5 例 g2 DCIS、5 例 g3 DCIS),并使用大组织切片进行组织学研究。在同一大切片中,从彼此最远的位置仔细激光显微解剖 DCIS 病灶,并对相关细胞进行遗传研究。如有浸润性导管癌和同侧淋巴结转移和/或对侧病变,也会进行额外的显微解剖。纯化肿瘤细胞的 DNA,并对 mtDNA D-环区域进行测序。使用邻接法进行系统发育分析,以直观显示同一病例不同病灶之间的遗传距离。患者年龄为 36-87 岁(平均 65.1 岁)。所有 9 例广泛传播的 DCIS 均不是克隆性的。6 例显示多个相邻病灶的病例中有 4 例在 mtDNA 分析上存在克隆相关性。在本系列中,11/15 的 DCIS 表现为多个同步的原发性乳腺癌,彼此之间没有遗传关系。本研究结果进一步证实了乳腺癌也可能表现出“癌前病变”现象,与其他器官中已经提出的观点一致。

相似文献

1
Genetic clonal mapping of in situ and invasive ductal carcinoma indicates the field cancerization phenomenon in the breast.原位和浸润性导管癌的遗传克隆图谱表明乳腺癌中的“癌化现象”。
Hum Pathol. 2013 Jul;44(7):1310-9. doi: 10.1016/j.humpath.2012.09.022. Epub 2013 Jan 18.
2
Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.通过荧光原位杂交(FISH)在存档材料中检测Her-2/neu过表达和未表达的乳腺癌及其同步的良性、癌前和转移病变中Her-2/neu基因的扩增情况。
Mod Pathol. 2002 Feb;15(2):116-24. doi: 10.1038/modpathol.3880503.
3
Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.有证据表明,在乳腺导管癌进展过程中,细胞的分子变化先于形态学改变出现。
Breast Cancer Res. 2008;10(5):R87. doi: 10.1186/bcr2157. Epub 2008 Oct 17.
4
The impact of field cancerization on the extent of duct carcinoma in situ (DCIS) in breast tissue after conservative excision.保守切除术后,场癌化对乳腺组织中导管原位癌(DCIS)范围的影响。
Eur J Surg Oncol. 2016 Dec;42(12):1806-1813. doi: 10.1016/j.ejso.2016.07.005. Epub 2016 Aug 9.
5
Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study.乳腺单纯导管原位癌与伴浸润性疾病的导管原位癌之间的基因组差异:一项校准后的比较基因组杂交研究
Clin Cancer Res. 2008 Jul 15;14(14):4446-54. doi: 10.1158/1078-0432.CCR-07-4960.
6
The impact of large sections on the study of in situ and invasive duct carcinoma of the breast.大片段对乳腺原位癌和浸润性导管癌研究的影响。
Hum Pathol. 2007 Dec;38(12):1736-43. doi: 10.1016/j.humpath.2007.04.007. Epub 2007 Aug 21.
7
S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.S100A7(牛皮癣素)的表达与乳腺导管原位癌的侵袭性特征及Jab1的改变相关。
Breast Cancer Res. 2004;6(4):R308-15. doi: 10.1186/bcr791. Epub 2004 Apr 26.
8
Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.纯性普通导管增生作为乳腺癌前体时染色体改变的证据。
Oncol Rep. 2008 Jun;19(6):1469-75.
9
[Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].[Notch1甲基化在乳腺癌及乳腺导管内增生性病变中的检测及其临床意义]
Zhonghua Bing Li Xue Za Zhi. 2011 May;40(5):324-9.
10
Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer.乳腺柱状细胞病变向浸润性乳腺癌的表观遗传进展。
Breast Cancer Res Treat. 2012 Dec;136(3):705-15. doi: 10.1007/s10549-012-2301-4. Epub 2012 Oct 27.

引用本文的文献

1
Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance.从导管原位癌到浸润性乳腺癌的进展:分子特征及临床意义。
Signal Transduct Target Ther. 2024 Apr 3;9(1):83. doi: 10.1038/s41392-024-01779-3.
2
A computational model for the cancer field effect.一种癌症场效应的计算模型。
Front Artif Intell. 2023 Jul 4;6:1060879. doi: 10.3389/frai.2023.1060879. eCollection 2023.
3
Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ.
三阴性乳腺癌伴导管原位癌的临床病理特征和预后
J Cancer Res Clin Oncol. 2023 Oct;149(13):11181-11191. doi: 10.1007/s00432-023-04895-9. Epub 2023 Jun 24.
4
Mutational profiling of micro-dissected pre-malignant lesions from archived specimens.对存档标本中微切割的癌前病变进行突变分析。
BMC Med Genomics. 2020 Nov 18;13(1):173. doi: 10.1186/s12920-020-00820-y.
5
Alteration in lipid composition differentiates breast cancer tissues: a H HRMAS NMR metabolomic study.脂质组成的改变可区分乳腺癌组织:一项 H HRMAS NMR 代谢组学研究。
Metabolomics. 2018 Sep 3;14(9):119. doi: 10.1007/s11306-018-1411-3.
6
Functional Role of miRNAs in the Progression of Breast Ductal Carcinoma in Situ.miRNAs 在乳腺导管原位癌进展中的功能作用。
Am J Pathol. 2019 May;189(5):966-974. doi: 10.1016/j.ajpath.2018.06.025. Epub 2018 Sep 29.
7
Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence.导管原位癌中的肿瘤内异质性:混乱与后果
J Mammary Gland Biol Neoplasia. 2018 Dec;23(4):191-205. doi: 10.1007/s10911-018-9410-6. Epub 2018 Sep 7.
8
Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing.基于拓扑的单细胞测序鉴定乳腺肿瘤中的克隆性浸润。
Cell. 2018 Jan 11;172(1-2):205-217.e12. doi: 10.1016/j.cell.2017.12.007. Epub 2018 Jan 4.
9
Personal history of proliferative breast disease with atypia and risk of multifocal breast cancer.乳腺增生性疾病伴非典型增生的个人史与多灶性乳腺癌的风险。
Cancer. 2018 Apr 1;124(7):1350-1357. doi: 10.1002/cncr.31202. Epub 2017 Dec 20.
10
An evolutionary perspective on field cancerization.从进化角度看肿瘤异质性。
Nat Rev Cancer. 2018 Jan;18(1):19-32. doi: 10.1038/nrc.2017.102. Epub 2017 Dec 8.